The revamped project plan for the International Thermonuclear Experimental Reactor aims for "a scientifically and technically robust initial phase of operations, including deuterium-deuterium fusion ...
CORAL GABLES, Fla., April 28, 2025 (GLOBE NEWSWIRE) -- Relmada Therapeutics, Inc. (Nasdaq: RLMD, “Relmada”, “the Company”), a clinical-stage biotechnology company, today announced that positive ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback